Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients
Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients
Recruiting · NCT06800391 · Registry updated 2025-01-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Recruiting | Phase 2 | 2025-01-30 | NCT06800391 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 62 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fondazione Irccs Istituto Nazionale Dei Tumori | Milan | Italy | 99 |